CLINICAL_TRIALS
trial_result
· 2022-02-18
Clinical Trial Update: A Challenge Study to Assess the Safety, Immunogenicity and Efficacy of a Malaria Vaccine Candidate [Phase 1, Phase 2]
Summary
Phase 1/2 trial update evaluating a malaria vaccine candidate for safety, immunogenicity, and efficacy has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Oxford | Conditions: Malaria | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2022-02-18